ALKS vs EQIX · P/E 14, rev $1.56B vs P/E 79, rev $9.22B
Alkermes Plc (ALKS) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported EQIX revenue for 2025-12-31 was $9.22B. Net income was $1.35B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the ALKS and EQIX stock pages for the full models.
Not investment advice.